SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-031573
Filing Date
2023-03-13
Accepted
2023-03-13 09:00:53
Documents
13
Period of Report
2023-03-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm239329d1_8k.htm   iXBRL 8-K 34197
  Complete submission text file 0001104659-23-031573.txt   256905

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA eqrx-20230308.xsd EX-101.SCH 3844
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eqrx-20230308_def.xml EX-101.DEF 27301
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE eqrx-20230308_lab.xml EX-101.LAB 38173
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eqrx-20230308_pre.xml EX-101.PRE 25923
7 EXTRACTED XBRL INSTANCE DOCUMENT tm239329d1_8k_htm.xml XML 5477
Mailing Address 50 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET CAMBRIDGE MA 02139 6173152266
EQRx, Inc. (Filer) CIK: 0001843762 (see all company filings)

IRS No.: 861691173 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40312 | Film No.: 23725901
SIC: 2834 Pharmaceutical Preparations